Stelliam Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Range Resources
RRC
|
+$11.8M |
| 2 |
Delta Air Lines
DAL
|
+$4.68M |
| 3 |
United Airlines
UAL
|
+$2.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gogo Inc
GOGO
|
+$16.8M |
| 2 |
Heron Therapeutics
HRTX
|
+$15.6M |
| 3 |
Huntington Bancshares
HBAN
|
+$12.3M |
| 4 |
Nokia
NOK
|
+$8.28M |
| 5 |
UnitedHealth
UNH
|
+$7.69M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 70.13% |
| 2 | Industrials | 18.4% |
| 3 | Communication Services | 3.26% |
| 4 | Financials | 0% |
| 5 | Healthcare | 0% |
Similar funds
Stelliam Investment Management's Q2 2019 Portfolio in Review
As of Q2 2019, Stelliam Investment Management held 18 positions worth $404M, down 16% from $483M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Stelliam Investment Management withdrew a net $34.8M in Q2 2019, closing 9 positions and reducing 5 holdings. Its most notable exit was Heron Therapeutics, an estimated $15.6M position sold in full.
By sector, the portfolio is most concentrated in Energy at 70% of assets, up from 68% a quarter earlier, followed by Industrials and Communication Services.
Against the trend, Stelliam Investment Management added an estimated $11.8M to Range Resources.
- Stelliam Investment Management added most to Range Resources in Q2 2019, an estimated $11.8M increase.
- Stelliam Investment Management's biggest Q2 2019 reduction was Gogo Inc, cutting an estimated $16.8M.
- Stelliam Investment Management fully exited Heron Therapeutics in Q2 2019, selling an estimated $15.6M.
- Stelliam Investment Management's ten largest holdings make up 100% of its $404M portfolio in Q2 2019.
- Stelliam Investment Management opened 1 new position and closed 9 in Q2 2019.
- Stelliam Investment Management's portfolio value fell 16% quarter-over-quarter to $404M.
Based on Stelliam Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.